A former NASA Principal Investigator and Researcher Dr. Brian Hashemi is the CEO and Chairman of Novigenix SA, a Swiss TechBio delivering AI-enabled immune intelligence advancing drug development and patient care. Brian has extensive background in healthcare technology development and commercialization and has been an Assistant Professor at Baylor College of Medicine where he began his affiliation in the National Space Biomedical Research Institute. He holds a Ph.D. in Applied Physics from Cornell University, and an MBA in Entrepreneurship and Investment Management from The Wharton School. For 13 years he was responsible for the development of advanced technologies in the biomedical division of NASA in collaboration with the European Space Agency; flown on the Space Shuttle program on STS-81 and STS-84.